Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-21

Clinical Trial Update: NSAA NON-Interventional Study Protocol

View source ↗

Summary

This document provides an update on a non-interventional study protocol using NSAA for Duchenne muscular dystrophy and notes that the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Red Nucleus Enterprise Solutions, LLC | Conditions: Duchenne Muscular Dystrophy | Status: COMPLETED